On July 28, 2023, Christopher Loose, Ph.D., notified Frequency Therapeutics, Inc. that he would be resigning from his position as Chief Scientific Officer of the Company, effective July 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.93 USD | +7.52% | -5.71% | +31.30% |
Apr. 24 | Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing | MT |
Apr. 24 | Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.30% | 584M | |
+1.51% | 42.75B | |
+49.05% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Frequency Therapeutics, Inc. Announces the Resignation of Christopher Loose as Chief Scientific Officer